The GEO Group (GEO) Q1 2025 earnings summary

Executive summary

• Q1 2025 revenue was $604.6–$605 million, nearly flat year-over-year, with net income of $19.6 million and adjusted EBITDA of $99.8–$100 million, both down from Q1 2024.

• Two major ICE contract awards (Delaney Hall and Northlake) totaling 2,800 beds and over $130 million in annualized revenue, with ramp-up expected in the second half of 2025.

• $70 million investment to expand ICE service capabilities and management reorganization to support anticipated growth.

• GEO operates 98 facilities with approximately 77,000 beds globally, serving government agencies in the US and internationally.

• Major refinancing completed, pushing most debt maturities to 2029 and 2031.

Financial highlights

• Q1 2025 net income was $19.6 million ($0.14 per diluted share), down from $22.7 million in Q1 2024, on slightly lower revenue ($604.6–$605 million vs. $605.7–$606 million).

• Adjusted EBITDA declined to $99.8–$100 million from $117.6–$118 million year-over-year.

• Operating income for Q1 2025 was $60.98–$61 million, down from $79.6 million in Q1 2024.

• Secure services revenue grew 1.2–3% year-over-year, offset by a 10% decline in electronic monitoring segment revenue.

• Operating expenses rose 3% year-over-year, mainly due to higher labor and training costs; G&A expenses increased 9% year-over-year.

Outlook and guidance

• 2025 guidance: net income of $108–$125 million ($0.77–$0.89 per diluted share), revenue of ~$2.53 billion, adjusted EBITDA of $465–$490 million.

• Q2 2025 guidance: net income of $0.15–$0.17 per share, revenue of $615–$625 million, adjusted EBITDA of $110–$114 million.

• Capital expenditures for 2025 expected at $120–$135 million, including a $70 million ICE investment.

• Guidance excludes unannounced contract wins and assumes no major census growth at existing facilities or ISAP.

• Anticipates significant revenue and EBITDA growth in the second half of 2025 as new contracts ramp up.